Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 September;64(3) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 September;64(3):250-64

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  NUCLEAR MEDICINE IN PRECISION ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 September;64(3):250-64

DOI: 10.23736/S1824-4785.20.03264-1

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy

Maaike DOTINGA 1 , Dennis VRIENS 1, Floris van VELDEN 1, Linda HEIJMEN 1, James NAGARAJAH 2, 3, Rodney HICKS 4, Ellen KAPITEIJN 5, Lioe-Fee de GEUS-OEI 1, 6


To access the FULL TEXT of this article choose one of the two following options:

PURCHASE THE ARTICLE

You can access the full text of this article (PDF and HTML if available) for 2 days at a price of:  € 45,00.

SUBSCRIBERS/MEMBERS LOGIN


TO SUBSCRIBE

top of page